ATC Group: M02AA06 Etofenamate

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of M02AA06 in the ATC hierarchy

Level Code Title
1 M Musculo-skeletal system
2 M02 Topical products for joint and muscular pain
3 M02A Topical products for joint and muscular pain
4 M02AA Antiinflammatory preparations, non-steroids for topical use
5 M02AA06 Etofenamate

Active ingredients in M02AA06

Active Ingredient Description
Etofenamate

Etofenamate is a flufenamic acid derivative, which is readily transported through the skin and concentrated in inflamed tissue, where it exerts anti-inflammatory and analgesic effects by inhibiting the release of histamine, lysosomal enzymes and prostaglandin.

Related product monographs

Title Information Source Document Type  
ETOFLAM Gel Health Products Regulatory Authority (IE) MPI, EU: SmPC
FLOGOPROFEN Gel / Cutaneous spray solution Medicines Authority (MT) MPI, EU: SmPC
TRAUMON Gel Medicines Authority (MT) MPI, EU: SmPC

Medicines in this ATC group

Austria (AT)

Germany (DE)

Hong Kong (HK)

Ireland (IE)

Lithuania (LT)

Malta (MT)

Mexico (MX)

New Zealand (NZ)

Poland (PL)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.